DexCom EBITDA 2010-2025 | DXCM
DexCom annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- DexCom EBITDA for the quarter ending March 31, 2025 was $0.194B, a 26.11% increase year-over-year.
- DexCom EBITDA for the twelve months ending March 31, 2025 was $0.858B, a 1.1% increase year-over-year.
- DexCom 2024 annual EBITDA was $0.818B, a 4.34% increase from 2023.
- DexCom 2023 annual EBITDA was $0.784B, a 43.25% increase from 2022.
- DexCom 2022 annual EBITDA was $0.547B, a 48.75% increase from 2021.
| DexCom Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $818 |
| 2023 | $784 |
| 2022 | $547 |
| 2021 | $368 |
| 2020 | $367 |
| 2019 | $191 |
| 2018 | $-157 |
| 2017 | $-26 |
| 2016 | $-49 |
| 2015 | $-46 |
| 2014 | $-13 |
| 2013 | $-21 |
| 2012 | $-48 |
| 2011 | $-40 |
| 2010 | $-42 |
| 2009 | $-42 |
| DexCom Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $194 |
| 2024-12-31 | $247 |
| 2024-09-30 | $207 |
| 2024-06-30 | $210 |
| 2024-03-31 | $154 |
| 2023-12-31 | $269 |
| 2023-09-30 | $254 |
| 2023-06-30 | $172 |
| 2023-03-31 | $89 |
| 2022-12-31 | $162 |
| 2022-09-30 | $187 |
| 2022-06-30 | $121 |
| 2022-03-31 | $78 |
| 2021-12-31 | $33 |
| 2021-09-30 | $144 |
| 2021-06-30 | $125 |
| 2021-03-31 | $67 |
| 2020-12-31 | $124 |
| 2020-09-30 | $113 |
| 2020-06-30 | $83 |
| 2020-03-31 | $47 |
| 2019-12-31 | $116 |
| 2019-09-30 | $69 |
| 2019-06-30 | $11 |
| 2019-03-31 | $-5 |
| 2018-12-31 | $-156 |
| 2018-09-30 | $22 |
| 2018-06-30 | $2 |
| 2018-03-31 | $-25 |
| 2017-12-31 | $16 |
| 2017-09-30 | $4 |
| 2017-06-30 | $-10 |
| 2017-03-31 | $-37 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-14 |
| 2016-06-30 | $-16 |
| 2016-03-31 | $-16 |
| 2015-12-31 | $4 |
| 2015-09-30 | $-40 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $4 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-10 |
| 2013-12-31 | $0 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-8 |
| 2013-03-31 | $-9 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-15 |
| 2012-06-30 | $-13 |
| 2012-03-31 | $-14 |
| 2011-12-31 | $-11 |
| 2011-09-30 | $-12 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-11 |
| 2010-12-31 | $-9 |
| 2010-09-30 | $-12 |
| 2010-06-30 | $-10 |
| 2010-03-31 | $-10 |
| 2009-12-31 | $-9 |
| 2009-09-30 | $-11 |
| 2009-06-30 | $-12 |
| 2009-03-31 | $-10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $33.137B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $193.381B | 84.70 |
| Thermo Fisher Scientific (TMO) | United States | $148.604B | 17.98 |
| Edwards Lifesciences (EW) | United States | $43.989B | 28.84 |
| Alcon (ALC) | Switzerland | $42.675B | 28.84 |
| IDEXX Laboratories (IDXX) | United States | $40.337B | 46.36 |
| STERIS (STE) | Ireland | $23.875B | 26.33 |
| IQVIA Holdings (IQV) | United States | $23.701B | 13.28 |
| Mettler-Toledo (MTD) | United States | $23.155B | 27.54 |
| Waters (WAT) | United States | $20.612B | 29.08 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.146B | 0.00 |
| Hologic (HOLX) | United States | $12.096B | 13.14 |
| Sysmex ADR (SSMXY) | Japan | $10.632B | 30.16 |
| Penumbra (PEN) | United States | $10.399B | 81.62 |
| Masimo (MASI) | United States | $8.140B | 30.03 |
| Globus Medical (GMED) | United States | $7.982B | 19.02 |
| Glaukos (GKOS) | United States | $5.487B | 0.00 |
| Teleflex (TFX) | United States | $5.337B | 8.81 |
| TransMedics (TMDX) | United States | $4.203B | 91.36 |
| Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.175B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.284B | 13.60 |
| Veracyte (VCYT) | United States | $2.127B | 29.85 |
| Nihon Kohden (NHNKY) | Japan | $1.943B | 22.28 |
| Elekta AB (EKTAY) | Sweden | $1.922B | 17.28 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.380B | 0.00 |
| Artivion (AORT) | United States | $1.222B | 114.44 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.956B | 5.08 |
| SiBone (SIBN) | United States | $0.783B | 0.00 |
| IRadimed (IRMD) | United States | $0.650B | 32.96 |
| RxSight (RXST) | United States | $0.637B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.597B | 13.05 |
| NeuroPace (NPCE) | United States | $0.580B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.569B | 8.86 |
| Delcath Systems (DCTH) | United States | $0.561B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| AxoGen (AXGN) | United States | $0.504B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.494B | 13.15 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.333B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.219B | 13.27 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.175B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| 908 Devices (MASS) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.172B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.093B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.90 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.67 |
| Hyperfine (HYPR) | United States | $0.042B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.032B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.58 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |